Skip to main content

Table 3 Pregnancy outcomes of women with moderate-severe OHSS and controls

From: Frozen embryo transfer in the menstrual cycle after moderate-severe ovarian hyperstimulation syndrome: a retrospective analysis

Characteristic

Severe vs Moderate

Moderate vs Control

Severe vs Control

OR (95% CI)

OR (95% CI)

OR (95% CI)

Biochemical pregnancy rate (%, n)

0.69 (0.34-1.41)

0.73 (0.49-1.10)

0.51 (0.25-1.04)

Clinical pregnancy rate (%, n)

0.82 (0.41-1.66)

0.72 (0.49-1.07)

0.60 (0.29-1.21)

Ectopic pregnancy rate (%, n)

*0.00

7.61 (0.39-147.40)

*0.00

Early pregnancy abortion rate (%, n)

0.65 (0.15-2.95)

0.93 (0.46-1.87)

0.61 (0.13-2.77)

Childbirth

1.08 (0.53-2.20)

0.70 (0.48-1.02)

0.75 (0.37-1.54)

Pregnancy complication

 GDM (%, n)

*0.00

0.72 (0.12-4.37)

*0.00

 PIH (%, n)

*0.00

1.19 (0.28-5.15)

*0.00

 Placenta previa (%, n)

*0.00

201.40 (0.30-145,378.49)

*0.00

 Premature rupture of membranes (%, n)

*0.00

1.15 (0.22-5.93)

*0.00

 Postpartum hemorrhage

*0.00

6.65

2.06

 Preterm birth (%, n)

1.23 (0.34-4.54)

1.05 (0.52-2.14)

1.30 (0.35-4.82)

 Cesarean section (%, n)

0.86 (0.28-2.67)

0.61 (0.36-1.06)

0.53 (0.17-1.64)

 Neonatal congenital diseases (%, n)

*0.00

3.67

*0.00

 Neonatal death (%, n)

*0.00

8.91

0.70

 Other neonatal complication (%, n)

*0.00

1.71 (0.21-13.85)

*0.00

  1. Qualitative data are n (%); quantitative data are mean ± SD
  2. CI confidence interval, GDM gestational diabetes mellitus, PIH gestational hypertension, OR odds ratio, CI confidence interval. Multivariable was adjusted for BMI, basal serum follicle-stimulating hormone, basal serum estradiol2, basal serum prolactin, basal serum luteinising hormone, total gonadotropin dosage, total days of gonadotropin, number of follicles, serum estradiol2 level on trigger day, serum luteinising hormone, serum progesterone on trigger day, number of retrieved oocytes, number of transplantable embryos, number of high-quality embryos
  3. * Significant difference